Cited by 234Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 459 of the 461 references it cites were found in a registry or an index.

Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease

Open access

Agis-Torres, Angel, Sollhuber, Monica, Fernandez, Maria, Sanchez-Montero, J.M.·2014·Current Neuropharmacology

DOI 10.2174/1570159x113116660047PMC PMC3915347

Open this paper in CoChat — free account Open PDF

Abstract

The lack of an adequate therapy for Alzheimer's Disease (AD) contributes greatly to the continuous growing amount of papers and reviews, reflecting the important efforts made by scientists in this field. It is well known that AD is the most common cause of dementia, and up-to-date there is no prevention therapy and no cure for the disease, which contrasts with the enormous efforts put on the task. On the other hand many aspects of AD are currently debated or even unknown. This review offers a view of the current state of knowledge about AD which includes more relevant findings and processes that take part in the disease; it also shows more relevant past, present and future research on therapeutic drugs taking into account the new paradigm "Multi-Target-Directed Ligands" (MTDLs). In our opinion, this paradigm will lead from now on the research toward the discovery of better therapeutic solutions, not only in the case of AD but also in other complex diseases. This review highlights the strategies followed by now, and focuses other emerging targets that should be taken into account for the future development of new MTDLs. Thus, the path followed in this review goes from the pathology and the processes involved in AD to the strategies to consider in on-going and future researches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2174/1570159x113116660047

Cites

459 of 459 references verified0 citation errors · 0 not checkable

Statistics

Fig. (1) Some of the main current targets in AD research.CC BY-NC · PubMed Central

Fig. (2) The binding pattern of dronabinol (∆9-THC; (tetrahydrocannabinol) (white) and donepezil (black) to acetylcholinesterase is shown. The represented amino acids showed in the binding site are part of PAS, CAS and the active catalytic site of the enzyme.CC BY-NC · PubMed Central

Fig. (3) Conceptual map showing main trends in constructing hybrid molecules from approved molecules and well known pharmacophores, to obtain new multi-target-directed ligands.CC BY-NC · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Dönmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 443
Retracted
Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
Delrieu, J., Ousset, P., Caillaud, C., & Vellas, B. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07458.x · Cited by 147
Retracted
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Correspondence - Tranexamic acid for traumatic brain injury
(2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · doi:10.1016/s0140-6736 · Cited by 11,894
Science
(2023) · doi:10.1126/science · Cited by 6,063
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
American Journal of Pathology
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,961
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein
Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991) · Science · doi:10.1126/science.1678899 · Cited by 2,740

Show all 461 references

Sorted by citations

Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
Ivasiv, V., Albertini, C., Gonçalves, A. E., Rossi, M., & Bolognesi, M. L. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190619115735 · Cited by 396
Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
Makhoba, X. H., Viegas, C., Mosa, R. A., Viegas, F. P. D., & Pooe, O. J. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s257494 · Cited by 337
Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer’s disease
Guzior, N., Wi.eckowska, A., Panek, D., & Malawska, B. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106122628 · Cited by 323
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
Jouanne, M., Rault, S., & Voisin‐Chiret, A. S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.070 · Cited by 279
Antibacterial and antioxidant activities for natural and synthetic dual-active compounds
Martelli, G., & Giacomini, D. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.009 · Cited by 232
Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders
Maiese, K. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12804 · Cited by 202
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
Doostmohammadi, A., Jooya, H., Ghorbanian, K., Gohari, S., & Dadashpour, M. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01607-9 · Cited by 212
Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry
Mohamed, T., Shakeri, A., & Rao, P. P. N. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.049 · Cited by 185
Novel Tacrine–Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography
Zha, X., Lamba, D., Zhang, L., Lou, Y., Xu, C., Kang, D., Chen, L., Xu, Y., Zhang, L., Simone, A. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01119 · Cited by 135
The biological activities of butyrylcholinesterase inhibitors
Zhou, S., & Huang, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112556 · Cited by 132
Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride
Rochais, C., Lecoutey, C., Gaven, F., Giannoni, P., Hamidouche, K., Hedou, D., Dubost, E., Genest, D., Yahiaoui, S., Freret, T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00115 · Cited by 129
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)
Mishra, P., Kumar, A., & Panda, G. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.025 · Cited by 130
Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125
“The tau protein is a filamentous protein associated with microtubules; in healthy neuronal cells, following consecutive and reversible enzymatic processes of phosphorylation and dephosphorylation, it has the task of assembling and stabilizing microtubules and determining their binding with other components of the cyto…”
Background
Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
Duan, S., Guan, X., Lin, R., Liu, X., Yan, Y., Lin, R., Zhang, T., Chen, X., Huang, J., Sun, X., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.002 · Cited by 121
A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease
Jalili‐Baleh, L., Babaei, E., Abdpour, S., Bukhari, S. N. A., Foroumadi, A., Ramazani, A., Sharifzadeh, M. S., Abdollahi, M. R., & Khoobi, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.05.004 · Cited by 121
Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer’s Disease
Prati, F., Cavalli, A., & Bolognesi, M. (2016) · Molecules · doi:10.3390/molecules21040466 · Cited by 110
Design, synthesis and evaluation of novel ferulic acid- O -alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease
Sang, Z., Pan, W., Wang, K., Ma, Q., Yu, L., Yang, Y. G., Bai, P., Leng, C., Xu, Q., Li, X., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.039 · Cited by 103
Developments with multi-target drugs for Alzheimer’s disease: An overview of the current discovery approaches
González, J. F., Alcántara, A. R., Doadrio, A. L., & Sánchez-Montero, J. M. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1623201 · Cited by 98
Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Jones, M. R., Mathieu, É., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Yong, V. W., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 96
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer’s disease
Kumar, N., Kumar, V., Anand, P., Kumar, V., Dwivedi, A. R., & Kumar, V. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116742 · Cited by 98
Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions
Miculas, D. C., Negru, P. A., Bungau, S. G., Behl, T., Hassan, S. S. U., & Tit, D. M. (2022) · Cells · doi:10.3390/cells12010131 · Cited by 96
One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug
Hughes, R. E., Nikolic, K. M., & Ramsay, R. R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00177 · Cited by 93
4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
Kumar, B., Dwivedi, A. R., Sarkar, B., Gupta, S. K., Krishnamurthy, S., Mantha, A. K., Parkash, J., & Kumar, V. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00220 · Cited by 92
Multitarget drug design strategy against Alzheimer’s disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties
Li, Y., Qiang, X., Luo, L., Xia, Y., Xiao, G., Zheng, Y., Cao, Z., Sang, Z., Su, F., & Deng, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.048 · Cited by 92
Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease
Sang, Z., Wang, K., Zhang, P., Shi, J., Liu, W., & Tan, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.021 · Cited by 89
Design, synthesis and biological evaluation of novel donepezil–coumarin hybrids as multi-target agents for the treatment of Alzheimer’s disease
Xie, S., Lan, J., Wang, X., Wang, Z., Jiang, N., Li, F., Wu, J., Wang, J. Q., & Kong, L. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.02.023 · Cited by 88
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease
Wang, Y., Wang, H., & Chen, H. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094820 · Cited by 87
One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Chen, H., Qi, S., & Shen, J. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160620102055 · Cited by 86
Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets
Uddin, M. S., Al Mamun, A., Kabir, M. T., Ashraf, G. M., Bin-Jumah, M. N., & Abdel-Daim, M. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02116-9 · Cited by 86
Taking aim at Alzheimer's disease through the mammalian target of rapamycin
Maiese, K. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.941921 · Cited by 88
A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease
Palanimuthu, D., Poon, R., Sahni, S., Anjum, R., Hibbs, D. E., Lin, H.-Y. J., Bernhardt, P. V., Kalinowski, D. S., & Richardson, D. R. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.021 · Cited by 82
Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
Fan, D., Liu, L., Wu, Z., & Cao, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180419141613 · Cited by 80
Recent Progress in Repositioning Alzheimer'S Disease Drugs Based on a Multitarget Strategy
Santos, M. A., Chand, K., & Chaves, S. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0103 · Cited by 79
Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer’s disease
Lan, J., Hou, J., Liu, Y., Ding, Y., Zhang, Y., Li, L. J., & Zhang, T. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1256883 · Cited by 78
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors
Reis, J., Cagide, F., Estrada, M., Teixeira, J., Bagetta, D., Pérez, C., Uriarte, E., Oliveira, P. J., Ortuso, F., Alcaro, S., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.056 · Cited by 78
Design, synthesis and biological evaluation of novel coumarin- N -benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease
Lan, J., Ding, Y., Liu, Y., Kang, P., Hou, J., Zhang, X., Xie, S., & Zhang, T. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.055 · Cited by 76
Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1–42)-induced cognitive deficit rats
Garabadu, D., & Verma, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.006 · Cited by 75
Forkhead transcription factors: new considerations for alzheimer’s disease and dementia
Maiese, K. (2016) · Journal of Translational Science · doi:10.15761/jts.1000146 · Cited by 72
Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment
Бачурин, С. О., Shevtsova, E. F., Махаева, Г. Ф., Grigoriev, V. V., Boltneva, N. P., Ковалева, Н. В., Lushchekina, S. V., Shevtsov, P. N., Неганова, М. Е., Redkozubova, O. M., et al. (2017) · Scientific Reports · doi:10.1038/srep45627 · Cited by 69
Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease
Bai, P., Wang, K., Zhang, P., Shi, J., Cheng, X., Zhang, Q., Zheng, C., Cheng, Y., Yang, J., Lü, X., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111737 · Cited by 67
Synthesis and evaluation of 4-hydroxyl aurone derivatives as multifunctional agents for the treatment of Alzheimer’s disease
Li, Y., Qiang, X., Luo, L., Li, Y., Xiao, G., Tan, Z., & Deng, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.012 · Cited by 65
Design, synthesis and pharmacological evaluation of N -benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates
Viegas, F. P. D., Silva, M. D. F., da Rocha, M. D., Castelli, M. R., Riquiel, M. M., Machado, R. P., Vaz, S. M., de Lima, L. M. S., Mancini, K. C., de Oliveira, P. C. M., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.066 · Cited by 64
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
Pachón-Angona, I., Refouvelet, B., Andrýs, R., Martin, H., Luzet, V., Iriepa, I., Moraleda, I., Diez‐Iriepa, D., Oset‐Gasque, M. J., Marco, J. L., et al. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1545766 · Cited by 60
Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy
Kou, X., Song, L., Wang, Y., Yu, Q., Ju, H., Yang, A., & Shen, R. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126927 · Cited by 59
Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design
Kumar, A., Tiwari, A. K., & Sharma, A. K. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180315141643 · Cited by 65
An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease
Calhoun, A. J., King, C., Khoury, R., & Grossberg, G. T. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1519022 · Cited by 62
Cholinesterase and carboxylesterase inhibitors as pharmacological agents
Махаева, Г. Ф., Рудакова, Е. В., Ковалева, Н. В., Lushchekina, S. V., Boltneva, N. P., Proshin, A. N., Shchegolkov, E. V., Burgart, Y. V., & Салоутин, В. И. (2019) · Russian Chemical Bulletin · doi:10.1007/s11172-019-2507-2 · Cited by 59
Marine AChE inhibitors isolated from Geodia barretti: natural compounds and their synthetic analogs
Olsen, E. K., Hansen, E. H., Moodie, L. W. K., Isaksson, J. M., Sepčić, K., Cergolj, M., Svenson, J., & Andersen, J. H. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob02416a · Cited by 61
Docking Studies for Multi-Target Drugs
Scotti, L., Mendonça, F. J. B., Ishiki, H. M., Ribeiro, F. F., Singla, R. K., Barbosa‐Filho, J. M., da Silva, M. S., & Scotti, L. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825111818 · Cited by 58
A second wind for the cholinergic system in Alzheimer’s therapy
Douchamps, V., & Mathis, C. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000300 · Cited by 61
Chemical composition and biological activity of Capparis spinosa L. from Lipari Island
Mollica, A., Stefanucci, A., Macedonio, G., Locatelli, M., Luisi, G., Novellino, E., & Zengin, G. (2018) · South African Journal of Botany · doi:10.1016/j.sajb.2018.02.397 · Cited by 58
Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways
Maiese, K. (2021) · Biomolecules · doi:10.3390/biom11071002 · Cited by 59
Acetylcholinesterase as a Multifunctional Target in Amyloid-Driven Neurodegeneration: From Dual-Site Inhibitors to Anti-Agregation Strategies
Grabowska, W. A., Bijak, M., Szelenberger, R., Gorniak, L., Podogrocki, M., Harmata, P., & Cichoń, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178726 · Cited by 65
Progress in Target Drug Molecules for Alzheimer's Disease
Xie, J., Liang, R., Wang, Y., Huang, J., Cao, X., & Niu, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191203113745 · Cited by 57
Isoindoline-1,3-dione derivatives targeting cholinesterases: Design, synthesis and biological evaluation of potential anti-Alzheimer’s agents
Szałaj, N., Bajda, M., Rakoczy, J., Brus, B., Gobec, S., & Malawska, B. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.045 · Cited by 55
Regeneration in the nervous system with erythropoietin
Maiese, K. (2015) · Frontiers in bioscience · doi:10.2741/4408 · Cited by 54
Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease
Shi, X., Wu, J., Liu, P., & Liu, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.001 · Cited by 55
Novel 3-phenylcoumarin–lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease
Jalili‐Baleh, L., Nadri, H., Forootanfar, H., Samzadeh‐Kermani, A., Küçükkılınç, T. T., Ayazgök, B., Rahimifard, M., Baeeri, M., Doostmohammadi, M., Firoozpour, L., et al. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.04.030 · Cited by 53
Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease
Wiciński, M., Domanowska, A., Wódkiewicz, E., & Malinowski, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082749 · Cited by 56
Inhibitory effect of corcin on aggregation of 1N/4R human tau protein in vitro.
Karakani, A. M., Riazi, G. H., Ghaffari, S. M., Ahmadian, S., Mokhtari, F., Firuzi, M. J., & Bathaie, S. Z. (2015) · Europe PMC (PubMed Central) · Cited by 51
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
Špilovská, K., Korábečný, J., Šepsová, V., Jun, D., Hrabinová, M., Jošt, P., Múčková, Ľ., Soukup, O., Janočková, J., Kucera, T., et al. (2017) · Molecules · doi:10.3390/molecules22061006 · Cited by 51
Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer’s disease
Zhang, X., Song, Q., Cao, Z., Li, Y., Tian, C., Yang, Z., Zhang, H., & Deng, Y. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.03.043 · Cited by 53
A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 57
Traditional Chinese Nootropic Medicine Radix Polygalae and Its Active Constituent Onjisaponin B Reduce β-Amyloid Production and Improve Cognitive Impairments
Li, X., Cui, J., Yu, Y., Li, W., Hou, Y., Wang, X., Qin, D.-P., Zhao, C., Yao, X., Zhao, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151147 · Cited by 49
Safranal protects against beta-amyloid peptide-induced cell toxicity in PC12 cells via MAPK and PI3 K pathways
Rafieipour, F., Hadipour, E., Emami, S. A., Asili, J., & Tayarani‐Najaran, Z. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0329-9 · Cited by 50
Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer’s Disease
Vrabec, R., Blunden, G., & Cahlíková, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054399 · Cited by 50
Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease
Fernandes, F., Barroso, M. F., De Simone, A., Emriková, E., Dias-Teixeira, M., Pereira, J. P., Chlebek, J., Fernandes, V. C., Rodrigues, F., Andrisano, V., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115107 · Cited by 45
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
Maiese, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1273570 · Cited by 48
Metabolomic profiling of Zanthoxylum species: Identification of anti-cholinesterase alkaloids candidates
Plazas, E., Casoti, R., Murillo, M. C. Á., Costa, F. B. D., & Suárez, L. E. C. (2019) · Phytochemistry · doi:10.1016/j.phytochem.2019.112128 · Cited by 46
Design, synthesis and evaluation of scutellarein- O -acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease
Sang, Z., Qiang, X., Li, Y., Xu, R., Cao, Z., Song, Q., Wang, T. I., Zhang, X., Liu, H., Tan, Z., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.054 · Cited by 43
Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles.
Ozadali-Sari, K., Küçükkılınç, T. T., Ayazgok, B., Balkan, A., & Unsal-Tan, O. (2017) · Bioorganic chemistry (Print) · doi:10.1016/j.bioorg.2017.04.018 · Cited by 33
Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
Patel, D. V., Patel, N. R., Kanhed, A. M., Patel, S. P., Sinha, A., Kansara, D. D., Mecwan, A. R., Patel, S. B., Upadhyay, P. N., Patel, K. B., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00226 · Cited by 45
6‐Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease
Semenov, V. E., Zueva, I. V., Mukhamedyarov, M. A., Lushchekina, S. V., Kharlamova, A. D., Petukhova, E. O., Михайлов, А. С., Podyachev, S. N., Saifina, L. F., Petrov, K. A., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500334 · Cited by 42
Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer's disease targets
Chlebek, J., Simone, A. D., Hošťálková, A., Opletal, L., Pérez, C., Pérez, D. I., Havlíková, L., Cahlíková, L., & Andrisano, V. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.01.008 · Cited by 43
Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy
Dgachi, Y., Sokolov, O., Luzet, V., Godyń, J., Panek, D., Bonet, A., Martin, H., Iriepa, I., Moraleda, I., García‐Iriepa, C., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.050 · Cited by 42
Protective effects of Forsythoside A on amyloid beta-induced apoptosis in PC12 cells by downregulating acetylcholinesterase
Yan, X., Chen, T., Zhang, L., & Du, H. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.009 · Cited by 40
Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer’s disease
Lan, J., Zeng, R., Jiang, X., Hou, J., Liu, Y., Hu, Z.-H., Li, H., Li, Y., Xie, S., Ding, Y., et al. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103413 · Cited by 41
Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation
Remya, C., Dileep, K. V., Reddy, E. K., Mantosh, K., Kesavan, L., Jacob, R. S., Sajith, A. M., Variyar, E. J., Anwar, S., Zhang, K. Y. J., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.041 · Cited by 42
Design, Synthesis, and Biological Evaluation of Piperazine and N -Benzylpiperidine Hybrids of 5-Phenyl-1,3,4-oxadiazol-2-thiol as Potential Multitargeted Ligands for Alzheimer’s Disease Therapy
Waiker, D. K., Verma, A., Akhilesh, A., Gajendra, T. A., Singh, N., Roy, A., Dilnashin, H., Tiwari, V., Trigun, S. K., Singh, S. P., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00245 · Cited by 40
Rosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation
Husain, I., Akhtar, M., Abdin, M. Z., Islamuddin, M., Yar, M. S., & Najmi, A. K. (2017) · Human & Experimental Toxicology · doi:10.1177/0960327117705431 · Cited by 39
Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer’s disease
Lalut, J., Payan, H., Davis, A., Lecoutey, C., Legay, R., Santos, J. S. O., Claeysen, S., Dallemagne, P., & Rochais, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-59805-7 · Cited by 41
Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage
Földes, A., Kádár, K., Kerémi, B., Zsembery, Á., Gyires, K., Zádori, Z., & Varga, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160121115210 · Cited by 40
Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta
Hebda, M., Bajda, M., Więckowska, A., Szałaj, N., Pasieka, A., Panek, D., Godyń, J., Wichur, T., Knez, D., Gobec, S., et al. (2016) · Molecules · doi:10.3390/molecules21040410 · Cited by 37
Discovery of in Vivo Chemical Probes for Treating Alzheimer’s Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors
Rabal, O., Sánchez-Arias, J. A., Cuadrado‐Tejedor, M., de Miguel, I., Pérez-González, M., García, C., Ugarte, A., de Mendoza, A. E., Sáez, E., Espelosin, M., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00648 · Cited by 38
Pharmacological Interventions to Attenuate Alzheimer’s Disease Progression: The Story So Far
Bazzari, F. H., Abdallah, D. M., & El-Abhar, H. S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190301111120 · Cited by 39
Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease
Cao, Z., Song, Q., Yu, G., Liu, Z., Cong, S., Tan, Z., & Deng, Y. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116074 · Cited by 37
Erythropoietin and mTOR: A “One-Two Punch” for Aging-Related Disorders Accompanied by Enhanced Life Expectancy
Maiese, K. (2016) · Current Neurovascular Research · doi:10.2174/1567202613666160729164900 · Cited by 37
Galectin-3 Secreted by Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Reduces Aberrant Tau Phosphorylation in an Alzheimer Disease Model
Lim, H., Lee, D., Choi, W.-K., Choi, S. J., Oh, W., & Kim, D. H. (2020) · Stem Cells International · doi:10.1155/2020/8878412 · Cited by 36
Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm
Maiese, K. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4971 · Cited by 36
Multifunctional thioxanthone derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer’s disease
Luo, L., Li, Y., Qiang, X., Cao, Z., Xu, R., Xia, Y., Xiao, G., Song, Q., Tan, Z., & Deng, Y. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.02.027 · Cited by 35
Multitarget trehalose-carnosine conjugates inhibit Aβ aggregation, tune copper(II) activity and decrease acrolein toxicity
Grasso, G. I., Bellia, F., Arena, G., Satriano, C., Vecchio, G., & Rizzarelli, E. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.060 · Cited by 35
Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases
Бачурин, С. О., Махаева, Г. Ф., Shevtsova, E. F., Boltneva, N. P., Ковалева, Н. В., Lushchekina, S. V., Рудакова, Е. В., Dubova, L. G., Vinogradova, D. V., Sokolov, V. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41272-4 · Cited by 35
Role of Acetylcholinesterase in β-Amyloid Aggregation Studied by Accelerated Molecular Dynamics
Lushchekina, S. V., Kots, E. D., Novichkova, D. A., Petrov, K. A., & Masson, P. (2016) · BioNanoScience · doi:10.1007/s12668-016-0375-x · Cited by 35
Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease
Sang, Z., Pan, W., Wang, K., Ma, Q., Yu, L., & Liu, W. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.03.070 · Cited by 33
Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease
Wu, M., Ma, J., Ji, L., Wang, M., Han, J., & Li, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.055 · Cited by 31
A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth
Shi, X.-L., Yan, N., Cui, Y.-J., & Liu, Z.-P. (2020) · Cells · doi:10.3390/cells9030649 · Cited by 26
MicroRNA-Based Multitarget Approach for Alzheimer’s Disease: Discovery of the First-In-Class Dual Inhibitor of Acetylcholinesterase and MicroRNA-15b Biogenesis
Gabr, M. T., & Brogi, S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00756 · Cited by 30
Discovery of novel hybrids containing clioquinol−1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease
Li, X., Li, T., Zhang, P., Li, X., Lu, L., Sun, Y., Zhang, B., Allen, S., White, L. J., Phillips, J. B., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114841 · Cited by 29
Focused design of polypharmacophoric neuroprotective compounds: Conjugates of γ-carbolines with carbazole derivatives and tetrahydrocarbazole
Махаева, Г. Ф., Sokolov, V. B., Shevtsova, E. F., Ковалева, Н. В., Lushchekina, S. V., Boltneva, N. P., Рудакова, Е. В., Aksinenko, A. Y., Shevtsov, P. N., Евгеньевна, Н. М., et al. (2017) · Pure and Applied Chemistry · doi:10.1515/pac-2017-0308 · Cited by 28
Cognitive Impairment in Multiple Sclerosis
Maiese, K. (2023) · Bioengineering · doi:10.3390/bioengineering10070871 · Cited by 32

Authors: Agis-Torres, A., Sollhuber, M., Fernandez, M., & Sanchez-Montero, J. M.
Affiliations: Universidad Complutense de Madrid (ES)
Venue: Current Neuropharmacology
Publisher: Bentham Science Publishers Ltd.
Published: 2014-01-31
Volume: 12
Issue: 1
Pages: 2-36
ISSN: 1570-159X (ISSN-L)
DOI: 10.2174/1570159x113116660047
PMC: PMC3915347
OpenAlex: W2031507955
Cited by: 202
References: 461
Citations by year: 2026: 10 · 2025: 13 · 2024: 10 · 2023: 12 · 2022: 18 · 2021: 11 · 2020: 18 · 2019: 24 · 2018: 21 · 2017: 25 · 2016: 22 · 2015: 12 · 2014: 6
FWCI: 15.81
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Current Neuropharmacology (publishedVersion)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, multi-target-directed ligands, Alzheimer's disease therapeutics, disease pathology, therapeutic drug development, complex diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks